domingo, 4 de marzo de 2018

Hereditary Cancers in Gynecology: What Physicians Should Know About Genetic Testing, Screening, and Risk Reduction. - PubMed - NCBI

Hereditary Cancers in Gynecology: What Physicians Should Know About Genetic Testing, Screening, and Risk Reduction. - PubMed - NCBI

 2018 Mar;45(1):155-173. doi: 10.1016/j.ogc.2017.10.011.

Hereditary Cancers in Gynecology: What Physicians Should Know About Genetic Testing, Screening, and Risk Reduction.

Abstract

Obstetrician gynecologists play a critical role in the identification of women who may carry a germline mutation placing them at an increased lifetime risk of gynecologic and nongynecologic cancers. Given this, all gynecologists must have a basic understanding of the most common hereditary cancer syndromes, the associated cancer risks, and possible risk-reducing interventions to play a proactive role in the care of these women. This article presents general guidelines and potential tools for identification of high-risk patients, reviews the current literature regarding genetic mutations associated with gynecologic malignancies, and proposes screening and risk-reduction options for high-risk patients.

KEYWORDS:

BRCA; Hereditary cancer syndrome; Lynch syndrome; Risk reduction; Screening

PMID:
 
29428283
 
DOI:
 
10.1016/j.ogc.2017.10.011

No hay comentarios:

Publicar un comentario